Genoskin was pleased to participate in the American Academy of Allergy, Asthma, & Immunology (AAAAI) Annual Meeting in Philadelphia, PA, one of the world’s leading scientific gatherings dedicated to allergy, asthma, and immunology research. The meeting convened leading clinicians, academic researchers, and industry scientists from around the globe to exchange insights on immune-mediated diseases, emerging therapeutic strategies, and advances in translational immunology.

Throughout the conference, Genoskin engaged in high-quality scientific discussions and shared expertise on human-relevant immunology, highlighting the value of ex vivo human skin and primary mast cell platforms for studying allergic and inflammatory immune responses. The event provided an excellent opportunity to connect with the research community and explore new collaborations aimed at advancing predictive, human-based approaches in immunology research.